Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines

被引：52

作者：

Gawad, Nagwa M. Abdel ^{[1
]}

Amin, Noha H. ^{[2
]}

Elsaadi, Mohammed T. ^{[2
]}

Mohamed, Fatma M. M. ^{[2
]}

Angeli, Andrea ^{[3
]}

De Luca, Viviana ^{[4
]}

Capasso, Clemente ^{[4
]}

Supuran, Claudiu T. ^{[3
]}

机构：

[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt

[2] Beni Suef Univ, Dept Med Chem, Fac Pharm, Bani Suwayf 62514, Egypt

[3] Univ Florence, Dipartimento Neurofarba, Sez Sci Farmaceut & Nutraceut, Via U Schiff 6, I-50019 Florence, Italy

[4] CNR, Ist Biosci & Biorisorse, Via Pietro Castellino 81, I-80125 Naples, Italy

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2016年 / 24卷 / 13期

关键词：

Carbonic anhydrase; Inhibitor; Sulfonamide; Antitumor; Cytotoxic agent; RAY CRYSTAL-STRUCTURE; HUMAN ISOFORM-II; ISOZYME-II; SELECTIVE INHIBITORS; THERAPEUTIC APPLICATIONS; SULFONAMIDE DERIVATIVES; XII INHIBITORS; BINDING; ANTICANCER; HYPOXIA;

D O I：

10.1016/j.bmc.2016.05.016

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of 4-(thiazol-2-ylamino)-benzenesulfonamides was synthesized and screened for their carbonic anhydrase (CA, EC 4.2.1.1) inhibitory and cytotoxic activity on human breast cancer cell line MCF-7. Human (h) CA isoforms I, II and IX were included in the study. The new sulfonamides showed excellent inhibition of all three isoforms, with K(I)s in the range of 0.84-702 nM against hCA I, of 0.41-288 nM against hCA II and of 5.6-29.2 against the tumor-associated hCA IX, a validated anti-tumor target, with a sulfonamide (SLC-0111) in Phase I clinical trials for the treatment of hypoxic, metastatic solid tumors overexpressing CA IX. The new compounds showed micromolar inhibition of growth efficacy against breast cancer MCF-7 cell lines. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：3043 / 3051

页数：9

共 43 条

[21] Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene) amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies
Eldehna, Wagdy M.
Abo-Ashour, Mahmoud F.
Nocentini, Alessio
Gratteri, Paola
Eissa, Ibrahim H.
Fares, Mohamed
Ismael, Omnia E.
Ghabbour, Hazem A.
Elaasser, Mahmoud M.
Abdel-Aziz, Hatem A.
Supuran, Claudiu T.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 139 : 250 - 262
[22] Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae - and -class enzymes
Bua, Silvia
Berrino, Emanuela
Del Prete, Sonia
Murthy, Vallabhaneni S.
Vijayakumar, Vijayaparthasarathi
Tamboli, Yasinalli
Capasso, Clemente
Cerbai, Elisabetta
Mugelli, Alessandro
Carta, Fabrizio
Supuran, Claudiu T.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2018, 33 (01) : 1125 - 1136
[23] Dinuclear triphenylphosphinegold(I) sulfanylcarboxylates: Synthesis, structure and cytotoxic activity against cancer cell lines
Barreiro, Elena
Casas, Jose S.
Couce, Maria D.
Sanchez, Agustin
Sanchez-Gonzalez, Angeles
Sordo, Jose
Varela, Jose M.
Vazquez Lopez, Ezequiel M.
JOURNAL OF INORGANIC BIOCHEMISTRY, 2010, 104 (05) : 551 - 559
[24] Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII
George, Riham F.
Said, Mona F.
Bua, Silvia
Supuran, Claudiu T.
BIOORGANIC CHEMISTRY, 2020, 95
[25] 9,10-Dibromo-N-aryl-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-diones: Synthesis and Investigation of Their Effects on Carbonic Anhydrase Isozymes I, II, IX, and XII
Goksu, Haydar
Topal, Meryem
Keskin, Ali
Gultekin, Mehmet S.
Celik, Murat
Gulcin, Ilhami
Tanc, Muhammet
Supuran, Claudiu T.
ARCHIV DER PHARMAZIE, 2016, 349 (06) : 466 - 474
[26] The synthesis of novel pyrazole-3,4-dicarboxamidesbearing 5-amino-1,3,4-thiadiazole-2-sulfonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II
Mert, Samet
Alim, Zuhal
Isgor, Mehmet Mustafa
Beydemir, Sukru
Kasimogullari, Rahmi
BIOORGANIC CHEMISTRY, 2016, 68 : 64 - 71
[27] Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes
Yamali, Cem
Gul, Halise Inci
Ece, Abdulilah
Taslimi, Parham
Gulcin, Ilhami
CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 91 (04) : 854 - 866
[28] Synthesis of 4,5-disubstituted-2-thioxo-1,2,3,4-tetrahydropyrimidines and investigation of their acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase I/II inhibitory and antioxidant activities
Garibov, Emin
Taslimi, Parham
Sujayev, Afsun
Bingol, Zeynebe
Cetinkaya, Songul
Gulcin, Ilhami
Beydemir, Sukru
Farzaliyev, Vagif
Alwasel, Saleh H.
Supuran, Claudiu T.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 : 1 - 9
[29] Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII
Brzozowski, Zdzislaw
Slawinski, Jaroslaw
Innocenti, Alessio
Supuran, Claudiu T.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) : 3656 - 3661
[30] Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies
Zolnowska, Beata
Slawinski, Jaroslaw
Szafranski, Krzysztof
Angeli, Andrea
Supuran, Claudiu T.
Kawiak, Anna
Wieczor, Milosz
Zielinska, Joanna
Baczek, Tomasz
Bartoszewska, Sylwia
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 1931 - 1941

← 1 2 3 4 5 →